Fed Chair Kevin Warsh's private venture fund buy raises ethics questions
As seen on the 24/7 Wall St. homepage on November 11, 2026.
- TAW LLC: TAW Fund I-A LLC: NanosVet, Inc. (pet care)Buy$50K – $100KSep 18
The sitting Fed chair bought into a private venture fund stake while markets parse his inflation stance, and it took 54 days to surface. Private, illiquid holdings sit outside the stricter 2021 Fed trading rules written for stocks and funds, which is why ethics watchers will press on this one.
Continue ReadingShow less
Kevin Warsh, serving as Chair of the Federal Reserve Board of Governors, purchased a stake in TAW Fund I-A LLC, a private venture fund with exposure to NanosVet Inc., a pet care company. The transaction, in the range of $50K to $100K, took place on September 18, 2026, and was not disclosed until a filing dated October 7, 2026, a lag of 54 days.
The delay matters because the Fed chair's investment decisions carry unusual weight. Markets are actively scrutinizing Warsh's posture on inflation and monetary policy, and any personal financial move, even one made in a private fund, invites questions about how his portfolio interests align with the rate decisions he oversees.
Sponsored
The 2021 Federal Reserve trading rules, written in response to earlier ethics controversies, imposed stricter restrictions on officials buying individual stocks and publicly traded funds. Private, illiquid holdings like this venture fund stake sit in a gap those rules did not close, which is precisely why ethics observers are focusing on this disclosure.
That regulatory gap means Warsh was not necessarily in violation of any standing rule. Even so, the combination of a 54-day disclosure lag, a private and hard-to-value asset, and the Fed's current moment in the inflation cycle gives ethics watchdogs concrete grounds to press for tighter standards covering private fund investments by senior monetary policymakers.